LINC02618

Across TCGA pan-cancer cohorts, LINC02618 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02618 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02618 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02618 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.

MESO, BRCA, and READ are the cancer types where LINC02618 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
BRCA	OS	Median	All	0.676	0.480	.006	42	view →
READ	DFS	Quartile	IV	0.227	0.656	.001	40	view →
ACC	DFS	Median	II,III,IV	0.386	0.754	.005	35	view →
KICH	DFS	Quartile	All	0.553	0.917	.005	28	view →
LUSC	OS	Tertile	IV	0.057	0.786	.017	25	view →
LAML	DFS	Tertile	All	0.531	0.327	.011	24	view →
LIHC	OS	Tertile	All	0.685	0.820	.001	21	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
LUAD	OS	Median	All	0.863	0.715	.002	12	view →
COAD	DFS	Tertile	II,III,IV	0.689	0.777	.011	11	view →
UVM	OS	Tertile	III,IV	0.227	0.692	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02618–MESO (OS)

Open the MESO breakdown →